Nature Communications (Sep 2018)
Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers
Abstract
Fluorescent tracers are being tested in clinical trials to improve detection of tumor margins, but procedures are not standardised. Here, the authors develop an analytical framework that is compatible with the workflow in the operating theatre, and show that it leads to an 88% increase in intraoperative detection of tumor margins in patients with breast cancer.